Science
Aldo Vidinha on AI Drug Discovery: Faster Molecules, Unchanged Attrition
One published Phase IIa readout. Multiple discontinued programmes. Zero approvals. The pharmaceutical quality and validation specialist sets out an evidence hierarchy for a sector that keeps presenting one level of proof as another, and explains why the real opportunity sits in the decision layer rather than in generative chemistry.
NASA Orbiter Finds New 222-Meter Crater on the Moon
McGetchin crater, formed in 2024, is the largest impact spotted during the Lunar Reconnaissance Orbiter’s mission.
EyePoint Pharmaceuticals Agrees to Pay $4.6 Million to Settle False Claims Act Allegations
Massachusetts based drugmaker resolves claims it used kickbacks and free samples to boost sales of an eye medication used after cataract surgery, highlighting ongoing scrutiny of pharmaceutical marketing practices.
There Are Early Signals Ahead of Tafamidis Trial As Analysts See Potential Upside for Pfizer (PFE) and BridgeBio Pharma (BIO)
PharmaWire has reported on the tafamidis patent trial ahead of its scheduled court date on 27 April. Analysts have pointed to early signs that may be shaping expectations for Pfizer (NYSE: PFE), BridgeBio (NASDAQ: BBIO) and the broader ATTR-CM market.
UC Irvine Astronomers Gauge Livability of Exoplanets Orbiting White Dwarf Stars
Computer model comparison reveals rotational factors contributing to habitability.
NASA Announces Uncrewed Return of Boeing’s Starliner and Continuation of Astronaut Missions
Photo caption: NASA Administrator Bill Nelson and leadership host a live news conference on Saturday, Aug. 24, at the agency's Johnson Space Center in Houston to give a status update about NASA's Boeing Crew Flight Test.
